Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenol Neurolysis for Chronic Knee Pain Post-TKA
NCT03973177Phase 4Withdrawn
- Sponsor
- Northwestern University
- Start
- May 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, single-blind trial of phenol in Chronic knee pain, sponsored by Northwestern University. Primary endpoint: Oxford Knee Score at 3 months. Planned start May 2019; status: withdrawn.
02
Drugs
phenol
03
Conditions
Chronic knee pain
Beyond the preview
Go deeper on NCT03973177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03973177.